Similarly, Natriuretic peptides such as Atrial Natriuretic Peptides (ANPs) and B-Type Natriuretic Peptide (BNP) have been found to inhibit NLRP3 inflammasome and its associated inflammatory response in prostate cancer [205]. The gene discussed is NLRP3; the disease is prostate carcinoma.